(Q39209851)

10 September 2017

Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk (English)

1 reference

head and neck squamous cell carcinoma

10 September 2017

1 reference

Abul K Azad

6

0 references

Shao Hui Huang

Shao Hui Huang

12

0 references

Fei-Fei Liu

Fei-Fei Liu

15

0 references

Geoffrey Liu

Geoffrey Liu

23

0 references

Brian O'Sullivan

Brian O'Sullivan

14

0 references

Jonathan Irish

21

Jonathan C Irish

1 reference

10 September 2017

3

David P Goldstein

1 reference

10 September 2017

Jennifer R Wang

1

1 reference

10 September 2017

Sarah J B Gramling

2

1 reference

10 September 2017

Dangxiao Cheng

4

1 reference

10 September 2017

Duoduo Chen

5

1 reference

10 September 2017

Alvina Tse

7

1 reference

10 September 2017

Henrique Hon

8

1 reference

10 September 2017

Zhuo Chen

9

1 reference

10 September 2017

Maryam Mirshams

10

1 reference

10 September 2017

Colleen Simpson

11

1 reference

10 September 2017

Stephanie Marquez

13

1 reference

10 September 2017

Heidi Roberts

16

1 reference

10 September 2017

Wei Xu

17

1 reference

10 September 2017

Dale H Brown

18

1 reference

10 September 2017

Ralph W Gilbert

19

1 reference

10 September 2017

Patrick J Gullane

20

1 reference

10 September 2017

David N Reisman

22

1 reference

10 September 2017

language of work or name

English

0 references

publication date

15 January 2013

1 reference

10 September 2017

1 reference

10 September 2017

34

1 reference

10 September 2017

5

1 reference

10 September 2017

1012-1017

1 reference

Global cancer statistics, 2002

10 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

The SWI/SNF complex and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Point-of-care outcome assessment in the cancer clinic: audit of data quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Human papillomavirus immortalization and transformation functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT008

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGT008

1 reference

10 September 2017

1 reference